DelveInsight’s "Angina (Angina Pectoris) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Angina (Angina Pectoris) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.
Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2016-2027
Angina (Angina Pectoris) Epidemiology The epidemiology section covers the historical, current as well as forecasted epidemiology for Angina (Angina Pectoris) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Angina (Angina Pectoris) outlook. It also includes the explanation of changing trends of epidemiology outlining the Angina (Angina Pectoris) scenario.
Angina (Angina Pectoris) Epidemiology Segmentation The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Angina (Angina Pectoris) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.
Report Scope • The report covers detailed overview of Angina (Angina Pectoris) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan • The Angina (Angina Pectoris) Report assesses the disease risk and burden and highlights the unmet needs • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population
Key strengths • 10 Year Forecast • 7MM Coverage • Total Cases in Angina (Angina Pectoris)
Key assessments • Patient Segmentation in Angina (Angina Pectoris) • Angina (Angina Pectoris) Risk & Burden • Factors driving growth in a specific Angina (Angina Pectoris) patient population
Our reports have been used by over 10K customers, including:
DelveInsight’s "Angina (Angina Pectoris) - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Angina (Angina Pectoris) epidemiology and market outlook for the 7MM. Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United...
Introduction DelveInsight’s, “Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" report provides comprehensive insights about marketed and Phase III products for Angina (Angina Pectoris) . The report includes information of marketed products including their product...
"Angina (Angina Pectoris) - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Angina (Angina Pectoris) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data...
Angina Pectoris Drugs Market Analysis, By Therapeutic Class (Beta Blockers, Calcium Antagonists, Nitrates, Anticoagulants, ACE inhibitors, Ranolazine), By Major Markets, And Segment Forecasts, 2016 - 2022 The global angina pectoris drugs market is expected to be valued at USD 10.6 Billion by 2022, as per a new report by Grand...
100 pages •
By Infiniti Research Limited
• Oct 2017
About Coronary Artery Disease Therapeutics Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries...